Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
19 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Shenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris) is a pharmaceutical company with a focus on research and development; manufacturing and distributing pharmaceutical and healthcare products. The companys cardiovascular and other specialty products include allie medoxomil, injection bivalirudin, clopidogrel bisulfate tablets, benazepril hydrochloride tablets, pamidronate disodium injection and desloratadine tablets. It offers antibiotics product such as cephalosporins cefepime hydrochloride, cefoxitin sodium, ceftriaxone sodium, cefotaxime sodium, ceftazidime, azithromycin dispersible tablets and cefoperazone sodium sulbactam.

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDPH222958D
Country
Industry
Ticker
002294=CN
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Shenzhen Salubris Pharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Shenzhen Salubris Pharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Shenzhen Salubris Pharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Shenzhen Salubris Pharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Shenzhen Salubris Pharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Shenzhen Salubris Pharmaceuticals Co., Ltd., Pharmaceuticals &Healthcare, Deal Details106
  Partnerships101
    Shenzhen Salubris To Form Joint Venture With Shanghai Pharma Company101
  Licensing Agreements111
    Shenzhen Salubris Pharma Enters Into Licensing Agreement With Shanghai Fosun Pharma For Diabetes Drug111
  Acquisition121
    Shenzhen Salubris Pharma Acquires Minority Stake in Suzhou Based Biotech Company for USD23.5 Million121
    Shenzhen Salubris Pharma Acquires 80% Stake in Chengdu Based Biotech Company131
    Shenzhen Salubris Pharma Acquires 24.06% Stake in Suzhou Based Biotech Company141
    Shenzhen Salubris Pharma to Acquire Shenzhen-Based Pharma Company for USD0.33 Million151
Shenzhen Salubris Pharmaceuticals Co., Ltd. - Key Competitors161
Key Employees171
Locations And Subsidiaries181
  Head Office181
Appendix191
  Methodology191
  About GlobalData191
  Contact Us191
  Disclaimer191

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Shenzhen-Salubris-Pharmaceuticals-Co-Ltd-002294-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24980>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Shenzhen-Salubris-Pharmaceuticals-Co-Ltd-002294-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24980>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research